You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 2, 2024

~ Buy the POLYETHYLENE GLYCOL 3350 Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

POLYETHYLENE GLYCOL 3350 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Polyethylene Glycol 3350, and when can generic versions of Polyethylene Glycol 3350 launch?

Polyethylene Glycol 3350 is a drug marketed by Ani Pharms, Annora Pharma, Aurobindo Pharma Ltd, Breckenridge Pharm, Elysium, Lgm Pharma, Mylan, Nexgen Pharma Inc, Novel Labs Inc, Nuvo Pharms Inc, Paddock Llc, Ppi-dac, Strides Pharma, and Teva Pharms. and is included in eighteen NDAs.

The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POLYETHYLENE GLYCOL 3350?
  • What are the global sales for POLYETHYLENE GLYCOL 3350?
  • What is Average Wholesale Price for POLYETHYLENE GLYCOL 3350?
Summary for POLYETHYLENE GLYCOL 3350
Drug patent expirations by year for POLYETHYLENE GLYCOL 3350
Drug Sales Revenue Trends for POLYETHYLENE GLYCOL 3350

See drug sales revenues for POLYETHYLENE GLYCOL 3350

Recent Clinical Trials for POLYETHYLENE GLYCOL 3350

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospitals Cleveland Medical CenterPhase 4
Changchun GeneScience Pharmaceutical Co., Ltd.Phase 1
Jinling Hospital, ChinaN/A

See all POLYETHYLENE GLYCOL 3350 clinical trials

Pharmacology for POLYETHYLENE GLYCOL 3350

US Patents and Regulatory Information for POLYETHYLENE GLYCOL 3350

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850-001 Dec 15, 2015 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 203928-002 Aug 24, 2016 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 078915-001 Oct 6, 2009 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.